Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.
Electronic gifts are very popular, and in recent years, retailers have been offering significant discounts on smartphones, ...
The United States Patent and Trademark Office (“USPTO” or the “Office”) released several memoranda[1] the week of December 1, ...
On October 30, 2025, in Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Nos. 2025-1210, 2025-1211, the US Court of Appeals for the ...
Artificial intelligence patenting in insurance is becoming a high-stakes, highly concentrated race dominated by a handful of U.S. carriers.
Every year has its “it” term.In 2025, the crown belonged to AI, and rightfully so. AI dominated the headlines, flooded the USPTO’s dockets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback